1. Home/
  2. Compounds/
  3. navitoclax:piperlongumine (1:1 mol/mol)

navitoclax:piperlongumine (1:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2navitoclax:piperlongumine (1:1 mol/mol)
PharmacoGx navitoclax:piperlongumine (1:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to navitoclax:piperlongumine (1:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA C2CD4C CTRPv2 pan-cancer AAC 0.21 2e-09
mRNA MTX1 CTRPv2 pan-cancer AAC -0.21 3e-09
mRNA MBTD1 CTRPv2 pan-cancer AAC 0.25 3e-09
mRNA SLC25A29 CTRPv2 pan-cancer AAC 0.21 3e-09
mRNA TMSB15B CTRPv2 pan-cancer AAC 0.22 3e-09
mRNA FANCF CTRPv2 pan-cancer AAC 0.22 3e-09
mRNA ZNF836 CTRPv2 pan-cancer AAC 0.21 3e-09
mRNA ZNF713 CTRPv2 pan-cancer AAC 0.21 4e-09
mRNA RUNDC3A CTRPv2 pan-cancer AAC 0.22 4e-09
mRNA TULP4 CTRPv2 pan-cancer AAC 0.21 4e-09
Download CSV